YSB

09885
3.0705.54% ( -0.180 )
Delay Closed: Nov 17, 16:08:15

Valuation

Current ValuationThe current P/E ratio is 9.94, below the reasonable range, cheaper than 99.62% of the time in the past 1 years, and the industry ranks 6/22, the industry Median 6.31.

9.94xP/E
Stock priceHK$3.07Earnings per shareHK$0.31

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.31x
05101520

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.31x
0x10x20x30x40x50x
P/E ratio
Name/Symbol
01099HKSINOPHARM
6.31x10.33%HK$52.65B
02607HKSH PHARMA
6.73x--HK$40.50B
00874HKBAIYUNSHAN PH
8.10x8.46%HK$20.42B
09885HKYSB
9.94x--HK$2.13B
06833HKSINCO PHARMA
7.67x--HK$268.34M
03390HKTYCOON GROUP
6.77x--HK$208.30M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.